Cargando…
Atezolizumab (programmed cell death-ligand 1 antibody)-induced inflammation of actinic keratosis: A case report
Atezolizumab is a programmed cell death-ligand 1 antibody that modulates the immune system response and has shown great promise in treating malignancies. Cutaneous toxicities from immune checkpoint inhibitors are the most commonly reported immune-related adverse events, although toxicities related t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661553/ https://www.ncbi.nlm.nih.gov/pubmed/36388634 http://dx.doi.org/10.1177/2050313X221131863 |